Comerica Bank decreased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 47.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 84,318 shares of the biotechnology company's stock after selling 74,824 shares during the quarter. Comerica Bank owned approximately 0.11% of Axon Enterprise worth $50,112,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of AXON. New Wave Wealth Advisors LLC bought a new stake in shares of Axon Enterprise in the 4th quarter valued at $40,000. Y.D. More Investments Ltd bought a new stake in Axon Enterprise during the fourth quarter valued at $45,000. Stonebridge Financial Group LLC acquired a new stake in Axon Enterprise during the 4th quarter worth about $53,000. GPS Wealth Strategies Group LLC raised its position in shares of Axon Enterprise by 74.1% in the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock worth $56,000 after acquiring an additional 40 shares in the last quarter. Finally, Versant Capital Management Inc lifted its stake in shares of Axon Enterprise by 4,750.0% in the 4th quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company's stock valued at $58,000 after purchasing an additional 95 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Axon Enterprise
In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the firm's stock in a transaction on Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the transaction, the chief executive officer now directly owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. This trade represents a 0.33 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jeri Williams sold 307 shares of the company's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares of the company's stock, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on the company. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. TD Cowen assumed coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective for the company. Barclays reissued a "hold" rating on shares of Axon Enterprise in a research note on Monday, March 10th. The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a research note on Monday, January 27th. Finally, Northcoast Research cut shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $626.45.
Check Out Our Latest Stock Analysis on Axon Enterprise
Axon Enterprise Stock Up 1.1 %
AXON stock traded up $7.06 during mid-day trading on Friday, reaching $628.16. 507,859 shares of the company traded hands, compared to its average volume of 758,459. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm's 50 day moving average price is $554.17 and its 200 day moving average price is $576.98. The stock has a market cap of $48.90 billion, a price-to-earnings ratio of 162.32, a P/E/G ratio of 5.17 and a beta of 1.24. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99.
Axon Enterprise Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.